Stockreport

Analysts Have Made A Financial Statement On Kymera Therapeutics, Inc.'s (NASDAQ:KYMR) Third-Quarter Report [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF The early response was not positive, with shares down 5.3% to US$46.47 in the past week. Statutory losses were a bit smaller than expected, at just US$0.82 per share, ev [Read more]